However, the median number of ASMs in use per patient remained constant in patients experiencing at least 1‐year of seizure freedom from focal seizures but showed a trend toward reduction (from 4 to 3) from the 12‐month visit to the 36‐month visit for patients experiencing at least 1 year of seizure freedom from all seizures and from TCS (see Table S2 ).
← all excerpts
One-year seizure freedom and quality of life in patients with drug-resistant epilepsy receiving adjunctive vagus nerve stimulation in Japan.
1
—
—